• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Phio Pharmaceuticals Corp. - Common Stock (NQ:PHIO)

    1.065 +0.025 (+2.40%)
    Streaming Delayed Price Updated: 2:22 PM EDT, Aug 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 117,517
    Open 1.030
    Bid (Size) 1.060 (900)
    Ask (Size) 1.070 (600)
    Prev. Close 1.040
    Today's Range 1.020 - 1.076
    52wk Range 0.8127 - 4.190
    Shares Outstanding 5,726,750
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Phio Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
    Strategic milestone advancements for lead clinical candidate PH-762 Initiation of commercial scale API, long term non-clinical toxicology, completion of Phase... 
    Via Newsfile
    News headline image
    Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    King of Prussia, Pennsylvania--(Newsfile Corp. - July 22, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical... 
    Via Newsfile

    Performance

    YTD
    -2.3%
    -2.3%
    1 Month
    +4.4%
    +4.4%
    3 Month
    -1.4%
    -1.4%
    6 Month
    +18.3%
    +18.3%
    1 Year
    -50.0%
    -50.0%

    More News

    Read More
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
    Via Newsfile
    Topics Intellectual Property
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
    Via Newsfile
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
    Via Newsfile
    News headline image
    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026 11 AM EDT
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Phio Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12, 2026, 11 AM EDT
    Via Newsfile
    News headline image
    Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update
    Via Newsfile

    Frequently Asked Questions

    Is Phio Pharmaceuticals Corp. - Common Stock publicly traded?
    Yes, Phio Pharmaceuticals Corp. - Common Stock is publicly traded.
    What exchange does Phio Pharmaceuticals Corp. - Common Stock trade on?
    Phio Pharmaceuticals Corp. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Phio Pharmaceuticals Corp. - Common Stock?
    The ticker symbol for Phio Pharmaceuticals Corp. - Common Stock is PHIO on the Nasdaq Stock Market
    What is the current price of Phio Pharmaceuticals Corp. - Common Stock?
    The current price of Phio Pharmaceuticals Corp. - Common Stock is 1.065
    When was Phio Pharmaceuticals Corp. - Common Stock last traded?
    The last trade of Phio Pharmaceuticals Corp. - Common Stock was at 08/10/26 02:22 PM ET
    What is the market capitalization of Phio Pharmaceuticals Corp. - Common Stock?
    The market capitalization of Phio Pharmaceuticals Corp. - Common Stock is 6.10M
    How many shares of Phio Pharmaceuticals Corp. - Common Stock are outstanding?
    Phio Pharmaceuticals Corp. - Common Stock has 6M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.